Market open
Galapagos/€GLPG
07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX
About Galapagos
Galapagos NV, abbreviated as GLPG on stock exchanges, is a global biotechnology firm specializing in the discovery and development of small molecule medicines. The company focuses on innovating treatments primarily in the fields of immunology and oncology. Founded in 1999, Galapagos operates out of its headquarters in Belgium and extends its reach across Europe and the United States, aiming to provide transformative therapies for significant unmet medical needs.
Ticker
€GLPG
Sector
Trading on
AEX
Industry
Biotechnology
Headquarters
Employees
704
Website
Galapagos Metrics
BasicAdvanced
€1.5B
-
-€2.57
-0.01
-
Price and volume
Market cap
€1.5B
Beta
-0.01
52-week high
€31.08
52-week low
€20.00
Average daily volume
106K
Financial strength
Current ratio
7.945
Quick ratio
7.736
Long term debt to equity
0.283
Total debt to equity
0.395
Interest coverage (TTM)
-217.59%
Management effectiveness
Return on assets (TTM)
-4.66%
Return on equity (TTM)
-6.36%
Valuation
Price to revenue (TTM)
5.355
Price to book
0.56
Price to tangible book (TTM)
0.61
Price to free cash flow (TTM)
-4.864
Growth
Revenue change (TTM)
18.31%
Earnings per share change (TTM)
-160.73%
3-year revenue growth (CAGR)
-17.18%
3-year earnings per share growth (CAGR)
10.36%
What the Analysts think about Galapagos
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Galapagos stock.
Galapagos Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Galapagos Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
FAQs
What’s the current market cap for Galapagos stock?
Galapagos (GLPG) has a market cap of €1.5B as of April 28, 2025.
What is the P/E ratio for Galapagos stock?
The price to earnings (P/E) ratio for Galapagos (GLPG) stock is 0 as of April 28, 2025.
Does Galapagos stock pay dividends?
No, Galapagos (GLPG) stock does not pay dividends to its shareholders as of April 28, 2025.
When is the next Galapagos dividend payment date?
Galapagos (GLPG) stock does not pay dividends to its shareholders.
What is the beta indicator for Galapagos?
Galapagos (GLPG) has a beta rating of -0.01. This means that it has an inverse relation to market volatility.